A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Category | Primary Site | Code? |
|---|---|---|---|
| Etidronate Disodium | Ancillary Agent | No | |
| Diethyldithiocarbamate | Ancillary Agent | No | |
| Urokinase | Ancillary Agent | No | |
| LymphoScan | Ancillary Agent | Lymphoma | No |
| Mecasermin | AIDS drug | No | |
| MDL-72222 | Ancillary Agent | No | |
| Ethambutol Hydrochloride | AIDS drug | No | |
| Naproxen Sodium | Ancillary Agent | No | |
| Voraxase | Ancillary Agent | No | |
| Meg-CSF | Ancillary Agent | No | |
| Etoprine | Ancillary Agent | No | |
| Verteporfin | Other therapy | Skin cancer | No |
| N-acetylcysteine | AIDS drug | No | |
| Naltrexone Hydrochloride | Ancillary Agent | No | |
| Nalaxone Hydrochloride | Ancillary Agent | No | |
| Acyclovir Sodium | AIDS drug | No | |
| Albuterol Sulfate | Ancillary Agent | No | |
| Albendazole | AIDS drug | No | |
| Fluorothymidine | AIDS drug | No | |
| Etretinate | Differentiation inducing agent | No | |
| Triflupromazine Hydrochloride | Ancillary Agent | No | |
| Stavudine | AIDS drug | No | |
| N1177 | Ancillary Agent | Other cancer | No |
| Nabilone | Ancillary Agent | No | |
| Diphenidol Hydrochloride | Ancillary Agent | No | |
| Dolasetron Mesylate | Ancillary Agent | No | |
| Trimethoprim | Ancillary Agent, AIDS drug | AIDS, Opportunistic infection | No |
| Mycophenolate Mofetil | Ancillary Agent | No | |
| U-87201E | AIDS drug | No | |
| Mycophenolic acid | Ancillary Agent | No | |
| Myristic acid analogs | AIDS drug | No | |
| Trimethobenzamide Hydrochloride | Ancillary Agent | No | |
| Trospectomycin Sulfate | AIDS drug | No | |
| MN rgp120/HIV-1 | AIDS drug | No | |
| Flurbiprofen | Ancillary Agent | No | |
| Fialuridine | AIDS drug | No | |
| Netivudine | AIDS drug | No | |
| Nevirapine | AIDS drug | No | |
| Trans-Retinoic Acid | Differentiation inducing agent | Leukemia, skin cancer | No |
| TLC G-65 | AIDS drug | No | |
| Mupirocin | Ancillary Agent | AIDS, Opportunistic infection | No |
| Mucopirocin | AIDS drug | No | |
| MSL-109 | AIDS drug | No | |
| MPI5020 | Ancillary Agent | Breast cancer | No |
| Ryoncil | Other therapy | No | |
| Trichosanthin | AIDS drug | No | |
| Proscar | Hormones and hormonal mechanisms | Prostate | No |
| Testosterone Phenylacetate | Hormones and hormonal mechanisms | No | |
| Morphine Sulfate | Ancillary Agent | No | |
| R-Verapamil HCl | Ancillary Agent | No |
| Name | Primary Site |
|---|---|
| BACO | |
| BACOD | |
| BACON | |
| BAMON | |
| BAVIP | |
| BBD | |
| BBVP-M | |
| BCAP | |
| BCAVe | |
| BCD | |
| BCMF | |
| BCP | |
| BCVP | |
| BCVPP-bleo | |
| BEACOPP | |
| BEMP | |
| BEP | Testicle |
| BIRD | |
| BLEO-COMF | |
| BOLD | Colorectal, skin |
| BOMP | |
| BONP | |
| BOPAM | |
| BOPP | |
| BV | |
| BVAM | |
| BVCPP | |
| BVDS | |
| Bevacizumab + IFL | |
| Biochemotherapy | |
| BuCyE | |
| C-TPF | Head and Neck, stomach |
| CAC | Breast, Ovary |
| CAF | Breast |
| CAFP | Breast |
| CAPIRI | Colorectal, Esophagus, Stomach |
| CAPOX | |
| CB | |
| CCAVV | Lung |
| CCNU-OP | Brain |
| CCVV | Lung |
| CCVVP | Lung |
| CEF | Breast |
| CEM | |
| CEPP | |
| CEV | |
| CFAR | |
| CFL | Head and Neck |
| CFM | Breast |
| CFPT |
Home